Regenerative Medical Technology Group Inc.
RMTG OTC
SEC CIK 1760026
Follow Regenerative Medical Technology
Weekly email: filings, results, news
Revenue, last quarter
$4M
+309.1% vs same quarter last year
Net income
−$2.9M
−101.3% vs same quarter last year
EPS, diluted
−$0.22
−83.3% vs same quarter last year
Operating cash flow
$332K
+155.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $5.1M | −$7.8M |
| FY24 | $4.1M | −$5.6M |
| FY23 | $2.4M | −$9.8M |
| FY22 | $1.5M | −$5.5M |
| FY21 | $437.9K | −$12.9M |
| FY20 | $55.1K | −$5.9M |
| FY19 | $30.1K | −$2.5M |
| FY18 | $50.1K | −$2.1M |
| FY17 | $29.2K | −$377K |
| FY16 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 55.1% | −17% | −153.2% |
| FY24 | 68.7% | 2% | −135.4% |
| FY23 | 69.5% | −29.7% | −407.2% |
| FY22 | 57.3% | - | −359.9% |
| FY21 | 34.3% | - | −2942.4% |
| FY20 | 20.2% | - | −10703.5% |
| FY19 | −84.4% | - | −8335.2% |
| FY18 | −36.4% | - | −4105.6% |
| FY17 | 83.6% | - | −1289.3% |
| FY16 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$1.3M |
| FY24 | $635.3K |
| FY23 | −$804.8K |
| FY22 | −$1.3M |
| FY21 | - |
| FY20 | −$422.7K |
| FY19 | −$462.3K |
| FY18 | −$248.6K |
| FY17 | - |
| FY16 | - |
- Regenerative Medical Technology
- Consumer median
Show the numbers
| Year | Regenerative Medical Technology | Consumer median |
|---|---|---|
| FY25 | −153.2% | 1.7% |
| FY24 | −135.4% | 2.3% |
| FY23 | −407.2% | 2.3% |
| FY22 | −359.9% | 2.7% |
| FY21 | −2942.4% | 2.8% |
| FY20 | −10703.5% | 1.3% |
| FY19 | −8335.2% | 2.2% |
| FY18 | −4105.6% | 2.8% |
| FY17 | −1289.3% | 2.6% |
| FY16 | - | 3.5% |
News
No stories filed under Regenerative Medical Technology yet - coverage appears here as the news feed clusters it.